Nalaganje...
A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures
In a prior report, we showed that extended-release guanfacine (GEXR) is safe and effective for children with autism spectrum disorder (ASD) accompanied by ADHD symptoms. Here, we examine the impact of GEXR on oppositional behavior, anxiety, repetitive behavior, and sleep disturbance. Sixty-two subje...
Shranjeno v:
| izdano v: | Neuropsychopharmacology |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer International Publishing
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6006142/ https://ncbi.nlm.nih.gov/pubmed/29540864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-018-0039-3 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|